Ramasamy, K., Bahlis, N. J., Kumar, S. K., Kumar, A., Cranmer, H., Wang, B., Dabora, J., Labotka, R., Richardson, P. G. and Moreau, P. (2024) “Adjusting for subsequent therapies in the TOURMALINE-MM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethasone”, Haematologica. Pavia, Italy, 109(8), pp. 2585-2593. doi: 10.3324/haematol.2023.283713.